Next-generation sequencing
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Shanghai Pulmonary Hospital, Shanghai, China
Overview
Next-generation sequencing is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Next-generation sequencing clinical trials
Explore related
Medical disclaimer. This page summarizes research about Next-generation sequencing for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.